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ABSTRACT
Objectives: Dressing primary surgical wounds is
common, but the implications for surgical site infection
(SSI) remain unknown. The Bluebelle study aimed to
determine the feasibility of a randomised controlled
trial (RCT) comparing ‘simple’, ‘complex’ or ‘no’
dressings on abdominal wounds, as prespecified in a
funder’s research brief. Bluebelle includes exploratory
work (phase A) to inform a pilot version of the
proposed RCT (phase B). Phase A aimed to investigate
current dressing practices and perspectives on the
proposed RCT, with a view to refining the forthcoming
pilot.
Design: Mixed methods, including semi-structured
interviews and document analysis.
Setting: 6 UK hospitals.
Participants: 51 patients and 92 clinical professionals
from abdominal surgical specialities.
Results: Professionals had variable interpretations of
what constitutes a ‘dressing’, particularly with respect
to ‘glue’—a product listed under ‘wound-closure
products’ in the British National Formulary, which
some surgeons reportedly applied as a ‘wound
covering’. Areas of ambiguity arising from interviews
informed development of pragmatic definitions,
including specification of conditions under which glue
constituted a ‘dressing’. Professionals reported that
‘simple’ dressings were routinely used in practice,
whereas ‘complex’ dressings were not. This raised
questions about the relevance of comparison groups,
prompting the design of a survey to determine the
types/frequency of dressing use in abdominal surgery
(reported elsewhere). This confirmed that complex
dressings were rarely used, while ‘glue as a dressing’
was used relatively frequently. ‘Complex dressings’
were therefore substituted for ‘glue as a dressing’
(following an updated Cochrane review, which found
insufficient evidence to determine the effectiveness of
‘glue as a dressing’). Patients and professionals
acknowledged uncertainty around dressing use and
SSI prevention, but felt dressings may serve practical
and/or psychological benefits. This steered
development of additional outcome measures for the
pilot.
Conclusions: Pre-trial qualitative research can
highlight areas of ambiguity and inform new lines of
enquiry in relation to prespecified research briefs,
enabling adjustments to RCT design that enhance
relevance to practice.
INTRODUCTION
Millions of operations are performed annu-
ally worldwide. Surgical procedures often cul-
minate in the wound edges being brought
together and secured using stitches, clips,
staples or tissue adhesive (‘glue’). Applying a
dressing over a surgically closed (primary)
wound is common after many operative pro-
cedures, although there is no evidence-based
rationale for this practice.1 A recent
Cochrane review concluded that there was
Strengths and limitations of this study
▪ The study presents a comprehensive and prac-
tical account of the ways in which qualitative
research instigated key changes to the design of
a prespecified randomised controlled trial (RCT)
of surgical wound dressing strategies.
▪ The reporting of the research process is novel,
emphasising the fluid and flexible nature of
investigations that were necessary in light
of emerging questions surrounding the relevance
of the funder’s research brief.
▪ The clinical context of the study enabled detailed
exploration of the reasons underpinning postsur-
gical wound dressing practices—an area that
was previously poorly understood.
▪ Patients’ and clinicians’ reported acceptability of
an RCT of wound dressing strategies were based
on hypothetical contexts, thus limiting the poten-
tial to understand actual reactions to a future
RCT.
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insufﬁcient evidence to recommend whether it is better
to apply a dressing over primary wounds or leave these
exposed to air (ie, without a dressing).2 The review also
found no evidence to recommend any particular type of
dressing over others. The studies collated in the review
considered a range of primary and secondary outcomes,
including appearance of scarring, pain control, patient
acceptability and surgical site infection (SSI) rates.
SSI prevention is a particular priority for healthcare
providers and policymakers due to the considerable
burden wound infections can inﬂict on patients and
healthcare systems.3–5 As such, one of the recommenda-
tions of the Cochrane review was for future randomised
controlled trials (RCTs) to investigate the impact of
dressing application on SSI prevention, focusing on sur-
gical specialities with the highest rates of SSI (eg,
gastrointestinal (GI) and obstetric procedures). The
UK’s National Institute for Health Research (NIHR)
subsequently issued a commissioned research brief, invit-
ing proposals for investigating the feasibility of conduct-
ing a large-scale RCT comparing ‘simple inexpensive
dressings’, ‘complex costly dressings’ and ‘no dressings’
on surgical wounds (see online supplementary informa-
tion 1). The Bluebelle feasibility study (HTA 12/200/
04) was funded in response to this brief. In our applica-
tion for funding, we deﬁned ‘feasibility’ as successful
delivery of a pilot RCT of ‘simple’, ‘complex’ and ‘no
dressings’ in the management of primary surgical
wounds. A ‘pilot’ RCT in this instance was deﬁned as a
small-scale version of a larger deﬁnitive RCT, run with
the intention of testing how the components of a main
RCT would work in practice.6
The success or failure of an RCT hinges on a number
of factors, including recruitment, adherence to proto-
cols/interventions, and the relevance of the research
question to key stakeholders (eg, patients, clinicians, pol-
icymakers). Surgical RCTs are notoriously difﬁcult to
deliver owing to a lack of experience in research and
individual surgeon preference.7 Planning with these
issues in mind requires a thorough understanding of the
clinical setting within which a trial will be conducted.
Little was known about the nature or frequency of dress-
ing use on postoperative wounds, the rationale under-
pinning these practices, or patients’ and professionals’
perceptions of equipoise around dressing strategies.
In light of the above uncertainties, the Bluebelle study
was designed to include a preparatory phase (phase A)
that aimed to reﬁne the design and protocol of the pilot
RCT (phase B). Speciﬁc objectives of phase A were to:
understand the reasons underpinning current choice
and use of dressings; deﬁne and categorise dressings
into the prespeciﬁed comparison groups, and explore
patients’ and professionals’ views on the proposed pilot
RCT. Phase A was originally intended as a qualitative
study with document analysis. However, unanticipated
emerging ﬁndings prompted the decision to conduct
additional research, in the form of a prospective survey,
and an update to the Cochrane review1 of dressings and
SSI prevention (both reported in full elsewhere).8 9 This
paper presents the qualitative ﬁndings in full, and refers
to the key ﬁndings from the additional research projects,
bringing these together to report how evolving feasibility
work transformed plans for the forthcoming pilot RCT.
METHODS
Phase A adopted a mixed-methods design, consisting of
qualitative interviews with healthcare professionals and
patients and document analysis of the British National
Formulary (BNF).10 The BNF is a pharmaceutical refer-
ence book, available in print and online, which sets out
legal and professional guidelines on prescribing medi-
cines. Information within the BNF includes names, legal
classiﬁcation, recommended doses, indications/contrain-
dications, side effects and prices of medicinal products.
The qualitative interviews and document analysis were
preplanned, but ﬁndings informed further (unantici-
pated) data collection and lines of enquiry. This
included a prospective survey (reported elsewhere)8 and
an update to an existing Cochrane systematic review1 9
Data from the above sources were regularly brought
together during study management group and steering
committee meetings to inform decisions about further
investigation and the eventual design of the pilot RCT.
The planned aspects of the feasibility study, and ways in
which they informed further lines of enquiry and the
ﬁnal RCT design, are reported here.
Qualitative interviews
Qualitative interviews investigated reasons underpinning
current wound dressing practices and patients’ and
healthcare professionals’ perspectives on the proposed
pilot RCT. Fulﬁlment of qualitative reporting guidelines
are available here (see online supplementary informa-
tion 2).
Context
Interviews were conducted across three university-
teaching National Health Service (NHS) hospitals and
three district NHS hospitals in the South West and
Midlands regions of England. These hospitals were
selected on the basis of practical considerations (dis-
tance from the institutions hosting the research), and an
intention to include a mix of hospitals (in terms of
university-teaching status). There was a focus on upper/
lower GI and obstetric (caesarean section) surgery,
based on the Cochrane review’s recommendations to
focus on operations that carried a high risk of SSI,4 and
speciﬁcation of these procedures in the funder’s
commissioned brief. Although we did not plan to
include children in the pilot RCT, interviews were also
conducted in paediatric surgery (in two sites) because
anecdotal information indicated that dressings were not
routinely used in paediatrics. The adult versus paediatric
comparison provided the potential to further the team’s
understanding of rationales for and against dressing use.
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Sampling and recruitment
Eligible healthcare professionals (professionals) worked
in upper/lower GI (general), obstetric and paediatric
surgical specialities, or were wound care specialists. All
were regularly involved in caring for surgical abdominal
wounds. Eligible patients were aged over 18 years, and
had undergone, or were scheduled to undergo, an
abdominal surgical procedure within 3 months of the
interview date. Surgical trainee research collaboratives,
research nurses, and principal investigators identiﬁed eli-
gible potential participants and sought consent to pass
on contact details to the qualitative research team (LR,
CM, DE, JM). As interviews progressed, sampling became
increasingly purposeful to achieve maximum variation
according to age, gender, type of surgery, and clinical
role (professionals only). The qualitative researchers
obtained written consent from patients and healthcare
professionals to conduct and audio-record the interviews.
Sampling and data collection ceased at the point of data
saturation, deﬁned as the point at which no new themes
emerged from three consecutive interviews (assessed sep-
arately for patients and healthcare professionals).
Data collection
Interviews were conducted face to face or via telephone
between July 2014 and July 2015 by LR, DE, CM and JM.
Face-to-face interviews took place on hospital and univer-
sity premises or in participants’ homes. Interviews with
clinical professionals lasted between 17 and 54 mins,
and interviews with patients lasted between 13 and
50 mins. Variability in staff interviews was largely due to
differences in clinical professionals’ time constraints.
Variability in patient interviews reﬂected differences in
individuals’ personal experiences of surgery, and the
type of surgery they had undergone/were scheduled to
undergo. These details had implications for patients’
reported experiences of wound healing. Furthermore, as
is often the case with qualitative research, interview par-
ticipants naturally differed in the extent to which they
spoke about their views and prior experiences, with
some individuals offering more detail, and speaking
more extensively, than others. An evolving topic guide
(see online supplementary information 3) was used to
ensure key topics were consistently covered, with the
team regularly meeting to update its content based on
emerging ﬁndings. New areas for investigation, or
factors that might have inﬂuenced interview conduct or
interpretation, were recorded in ﬁeld notes after inter-
views. The interviewers regularly discussed interview
content and technique during team meetings. This
ensured that difﬁcult trial concepts, such as ‘outcome
measures’, were explained consistently across interviews.
The team also agreed on particular strategies for build-
ing rapport with patients. For example, although inter-
views focused on dressing-related issues, there was
agreement that researchers would begin interviews with
open-ended questions about the patients’ experiences of
clinical care/recovery/symptoms.
Analysis
Interviews were transcribed and subjected to thematic
analysis, guided by constant comparison methods
adopted from grounded theory methodology.11
Transcripts were coded line by line in NVivo V.10 (QSR
International Pty V.10, 2012, Victoria, Melbourne,
Australia), with a subset (10%) coded by at least two
researchers at the start of data collection to inform an
initial coding framework. Some codes were developed a
priori, in line with the topic guide and focused study
objectives. Various levels of subcodes and additional
broad codes were added inductively as analysis pro-
ceeded. Members of the qualitative team met regularly
to discuss the evolving coding framework. Data were
summarised in matrices to help identify patterns of
responses based on participant characteristics (eg, surgi-
cal specialty, clinical role, etc). Descriptive accounts sum-
marising emerging themes were prepared for the study
management group throughout the analytical process.
Negative cases (ie, participants whose views did not align
with the major themes reported), were clearly identiﬁed
in reports/presentations of ﬁndings.
Document analysis
The ‘wound management products’ section of the
BNF10 was scrutinised for relevant information about
current dressing names, classiﬁcations and costs.
Extracted data were summarised in tables and consid-
ered alongside data emerging from the qualitative inter-
views to facilitate development of pragmatic deﬁnitions
for the trial comparison groups to be adopted in the
forthcoming pilot RCT. Listed BNF dressings were subse-
quently classiﬁed into these groups.
RESULTS
One hundred and forty-three qualitative interviews were
conducted (92 professionals, 51 patients), 102 of which
focused on current wound dressings practices (69 pro-
fessionals, 33 patients), and 41 on use of glue as a dress-
ing (23 professionals, 18 patients; tables 1–3). There
were no withdrawals.
Table 1 Role and surgical specialty of professional
participants interviewed about wound dressing practices
Surgical specialty
Participant type General Obstetric Paediatric Total
Surgeon 16 4 6 26
Registrar 6 3 3 12
Nurse/midwife 19 8 2 29
Tissue viability
specialist
1 0 0 1
Community district
nurse
1 0 0 1
Total 43 15 11 69
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Current practice and clinical equipoise
Paediatrics
Paediatric professionals from both sites reported that
they did not routinely apply dressings to primary wounds.
Leaving primary wounds exposed was assumed to be
common practice in paediatric surgery, although some
had encountered individual paediatric consultants who
did apply dressings. Most attributed their own practices
to local conventions, although some rationalised their
practices according to practical and psychological factors
speciﬁc to the paediatric population. Children were
thought to tamper with or remove dressings, experience
distress on dressing removal and feel anxious at the pros-
pect of not knowing what lies beneath a dressing:
Paediatric surgeon 1006: In paediatric surgery (we) have
not been using…a lot of us have not been using dressings
for ages because it’s a nightmare to get them off these
children again. They hate the feeling of peeling it off
and having to change those every 24 hours to look at the
wound and things like that. On wounds where the
chances of getting infection is sort of under half a per-
centage or something like that, you’re thinking that’s
probably unnecessary cruelty (laugh) in a way.
Some informants theorised that there had been no
incentive or trigger to question the tradition of leaving
primary wounds exposed, given the anecdotally observed
low SSI rates in paediatrics. This implied an assumption
that dressing application was linked with theories of SSI
prevention in other specialities:
Paediatric surgeon 1008: So I think they’ve (children)
got good cell turnover, they’ve got really good blood ﬂow.
They heal incredibly well, the [SSI] rates are low, so I
guess there’s no direct market for a company.
Adult surgery
In contrast to paediatrics, professionals working in adult
upper/lower GI and obstetric surgery reported that dres-
sings were routinely applied to primary wounds. Most
professionals emphasised that management of primary
wounds was very different to treating wounds that had
been intentionally left open (‘secondary’ wounds) or
wounds that had developed clinical problems. Secondary
and problematic wounds were described as highly hetero-
geneous, with complex individual needs. Care of these
wounds reportedly fell under the remit of wound specia-
lists, who were able to make reasoned dressing selections
that were tailored to the wound requirements. In con-
trast, dressing use in primary wounds was presented as a
largely passive process that had become indoctrinated
into postoperative practice, though there were isolated
reports of surgeons more actively choosing a particular,
comparatively novel, dressing product (‘glue’, see ‘Glue
as a dressing’ section). Overall, surgeons and nurses
reported little active clinical decision-making in dressing
primary wounds, using whatever ‘default dressing’ had
been purchased by the hospital. Although the speciﬁc
dressing brands used could vary temporally and across
hospitals, the default dressings described had similar
characteristics: all were adhesive coverings that had no
additional active properties.
Similar to the paediatric context, standard practices
in managing adult primary wounds were attributed to
convention and dogma. Professionals proposed a
number of theoretical advantages and disadvantages of
the default dressings they used, but acknowledged the
lack of evidence in this area. The theories proposed
were variable—particularly with respect to SSI preven-
tion; while some suggested that dressings may prevent
SSI by creating a barrier between the wound and
sources of contamination, others suggested that dres-
sings might promote the ideal conditions for bacteria
to thrive:
Obstetric surgery nurse 2008: So from my experience I
would say a wound dressing is to protect the wound, and
basically it’s to prevent infection, that’s what I would
believe it to do from my nursing practice and midwifery.
Table 2 Role and surgical specialty of professional
participants interviewed about ‘glue as a dressing’
Surgical specialty
Participant type General Obstetric Total
Surgeon 6 3 9
Registrar 3 4 7
Nurse/midwife 0 7 7
Total 9 14 23
Table 3 Patient participants interviewed about ‘wound dressing practice’ and ‘glue as a dressing’ according to the site of
their wounds
Number of patients
interviewed, categorised
according to type of surgery
received
TotalGeneral Obstetric
Focus of interview Wound dressing practices 26 7 33
Use of ‘glue as a dressing’ 18 0 18
Total 44 7 51
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The whole reason they have a dressing is to protect that
area from, you know, foreign bodies and bacteria and the
environment.
General surgeon 1005: I suppose the, the accepted
dogma would be that that protects the wound from infec-
tion because it’s sealed the skin…I don’t think…I would
be very surprised if it makes much of a difference in
terms of infection rates cos I sometimes think dressings
are sort of keep a wound warm and moist and that may
actually provide ideal incubation kind of environment for
bugs.
Professionals’ views were more polarised towards dres-
sings being beneﬁcial with respect to practical considera-
tions (eg, absorption of wound exudate), although some
posited that exposed wounds may be practically easier to
monitor and assess. Overall, all theories for/against
dressing use on primary wounds were tempered with
uncertainty and an acknowledged need for evidence:
General surgery nurse 3012: Unless we run trials to prove
whether they [dressings] are effective or not we’ll never
know will we?
General surgeon 1004: I would be prepared to consider
[not applying a dressing] in the context of a research
trial, because I accept that the evidence base is poor and
a lot of it reﬂects personal practice.
Acceptability of an RCT
All professionals supported the prospect of an RCT that
included a ‘no dressing’ group, as long as this focused
exclusively on primary surgical wounds. All accepted
that there was clinical equipoise about the relationship
between dressing use and SSI events in these wounds.
Nonetheless, some expressed reticence about practical
issues such as management of wound exudate (eg,
blood, tissue ﬂuid), and questioned whether patients
would accept the possibility of not receiving a dressing:
Obstetric surgeon 2001: There can be you know, a bit of
general ooze from the skin and fat layer which can be
quite difﬁcult to stop. So if you wanted to put a pressure
dressing on you would need to put a dressing on…
General surgery nurse 1002: They [patients] might not
like the idea of not having their wound covered […].
Very often they just don’t like the look, or they worry
about the wound opening up. Even though there’s no
clinical sign of the wound opening up, they get very con-
cerned about their wounds.
Conversely, there were also suggestions that patients
might welcome the opportunity of avoiding the poten-
tially painful experience of dressing removal, and may
begin the psychological recovery process sooner if con-
fronted with the exposed wound from the outset:
Obstetric nurse 2009: I expect some of them [patients]
will think “Oh good, I haven’t got to peel it off in the
shower,” because that’s not very pleasant either.
General surgery nurse 1001: Even if it is just a very, very
simple dressing they can look at that as a reason…(like)
“Oh can I shower with that? Or, “Is that going to stop me
from coughing?” So yes, it can be restrictive and detri-
mental psychologically to their recovery. I think not
having dressings will improve that. I think it will improve
the psychological recovery for patients.
Taken together, professionals’ accounts suggested that
there were balanced reasons for/against dressing use,
although the trial team would need to carefully consider
the inclusion/exclusion and withdrawal criteria in rela-
tion to wound exudate.
Most patients anticipated that they would participate
in an RCT of different dressing strategies, citing altruistic
reasons or an indifference about how their wound was
managed. Many of these patients had undergone, or
were scheduled to undergo, major surgery. To some,
dressing considerations were perceived as trivial when
considered in this hypothetical context. Some raised the
possible practical consequences of foregoing a dressing
(eg, wound-closure materials catching on clothing,
absorption of exudate), though only a minority felt these
concerns would deter them from RCT participation.
Those who were unfavourable towards RCT participation
tended to amalgamate practical considerations with psy-
chological concern (or ‘worry’, as reported by patients):
General surgery participant 1032: I think I would, just
because of the way that I…because of everything that I…
you know like knocking, catching, be a bit worried maybe.
Obstetric surgery participant 2001: The day after, two
days after, that’s ﬁne, I don’t mind not having a dressing
but straight after surgery, especially because it’s leaking
blood and all the rest of it, I would want it covered. It
would worry me.
A few patients who had prior experience of receiving
a dressing after surgery questioned whether foregoing a
dressing would be detrimental to wound healing or
increase the risk of infection. When it came to clinical
considerations, however, acceptability of the RCT
appeared to be entwined with whether their clinical
team (whom they trusted) supported trial participation:
General surgery patient 1031: I (would) think “Oh they
know best” and I just carry on with it and do what they
want me to do.
Defining potential comparison groups
Given that there was overall support for the RCT in prin-
ciple, further research explored the scope and deﬁnition
of ‘simple’, ‘complex’ or ‘no dressing’, and how these
might work in the context of the proposed pilot RCT.
Interpretations of ‘dressing’ and ‘no dressing’
Interviews revealed variable deﬁnitions of what consti-
tuted a ‘dressed’ and ‘undressed’ wound. Professionals
sought clariﬁcation on whether application of non-
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adherent products to absorb exudate (eg, gauze) would
breach a ‘no dressing’ allocation, and queried how par-
tially covered wounds should be categorised. This raised
the possibility that patients in a pilot RCT may be treated
inconsistently if allocated to a ‘no dressing’ group:
Paediatric surgeon 1013: I suppose I think of a dressing
as something that’s been used to deliberately cover up
and, in a sense, cover up the wound…and with
Steri-strips you leave gaps between them.
Obstetric registrar 2019: Vaginal operations there are no
dressings even though often then you use pads. Is that a
dressing because it is used to cover the wound? Would
that be considered a dressing? I would say that’s interest-
ing: because you don’t stick it on, it’s not a dressing.
Initial interviews introduced the unexpected use of
glue as a covering over primary wounds. Although the
BNF currently lists glue as a wound-closure product,
some professionals reported that this functioned as a
‘dressing’ when applied over an already closed wound.
The dual use of glue as a wound-closure product and
dressing was recognised as a potential source of confu-
sion in a future pilot RCT:
General surgery nurse 1014: I would say dressings are
something that occludes the skin, that covers the
wound…Steri-strips don’t. Glue doesn’t, but can do, but
doesn’t necessarily…
Interpretations of ‘simple’ and ‘complex’ dressings
Interview informants encountered difﬁculties in inter-
preting the ‘simple’ and ‘complex’ dressing categories
speciﬁed in the funder’s call. Professionals did not use
dressing classiﬁcations in routine management of
primary wounds. The tendency to use a single default
dressing in this context negated the need for any formal
dressing classiﬁcation in day-to-day practice:
General surgeon 1005: Hmm, does that mean anything
to me? No, but as a term… not really, but at the same
time simple dressing(s) probably are the ones we use
every day…
Despite professionals’ unfamiliarity with the proposed
dressing classiﬁcations, most could intuitively envisage
the types of dressings each group might encompass.
‘Simple’ was thought to be an apt descriptor for the
default dressings used on primary wounds, which were
consistently described as adhesive coverings that could
be absorptive or non-absorptive. ‘Complex’ dressings
were thought to have specialised functions that extended
beyond wound coverage and passive absorption of
exudate, although informants had limited experience of
using these:
General surgery nurse 1001: You’ve basically got dressings
that are simply a covering or a ﬁxation that are literally
just covering up something. They don’t have any proper-
ties other than they are covering up something […].
Then you’ve got some dressings that are very speciﬁc—
but we do occasionally use them—that have got anti-
microbial properties, so they’re trying to stop an infec-
tion. By far the one we use the most is the ﬁrst, so just a
simple covering. I would say 80 to 90% of our wounds
were just simple coverings.
Developing pragmatic definitions
The inconsistent interpretation of the proposed wound
dressing strategies, including the variable interpretations
of ‘dressing’, reiterated the need for clear-cut deﬁnitions
that could be used in the pilot RCT. Deﬁnitions needed
to be comprehensible to front-line professionals and
sufﬁciently exhaustive to encompass existing dressings
mentioned in the BNF. Deﬁnitions were iteratively devel-
oped across three study management group meetings,
supported by emerging data from interviews (table 4).
Working deﬁnitions were scrutinised by considering the
areas of controversy raised in relation to what constitutes
a ‘dressing’ (eg, issues of adherence, extent of wound
coverage), and professionals’ intuitive interpretations of
‘simple’ and ‘complex’ dressings. Wound care experts
reviewed the ﬁnal pragmatic deﬁnitions during a
Table 4 Bluebelle pragmatic definitions of dressing strategies
Dressing
strategy Bluebelle pragmatic definition
No dressing The absence of any covering applied to a closed wound at the end of the operation. If there is exudate
from the wound after surgery a simple gauze swab (basic wound contact dressing) may be applied/taped
to the area of the wound that is oozing. Note: Steristrips would fall under this category if they do not cover
the entire wound.
A simple
dressing
A covering (opaque or transparent) directly applied over the entirety of an already closed wound at the
end of the operation. It has adherent properties around its perimeter or its entire surface, and may have
pads to absorb exudate. It will not be amorphous, have silicone, hydrocolloid or foam. Note: Steristrips
would fall under this category if they cover the entire wound.
A complex
dressing
A covering that is directly applied over the entirety of an already closed wound at the end of the operation
which has intended advanced practical properties and/or therapeutic properties. This may include
amorphous material, silicone, hydrocolloid, foam, antimicrobials and it will exclude topical negative
pressure therapy.
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presentation at a national meeting and a study steering
committee meeting. Organising BNF-listed dressings
into these pragmatic categories revealed that ‘simple’
dressings encompassed products that cost no more than
£4 per item, while ‘complex’ dressings all cost over £4
per item. This aligned with details speciﬁed in the
funder’s commissioned call, which classed ‘simple’ dres-
sings as ‘inexpensive’, and ‘complex’ dressings as
‘expensive’ (see online supplementary information 4).
The relevance of comparison groups
Relevance of ‘simple’ and ‘complex’ dressings
Having developed a pragmatic categorisation of dres-
sings, questions remained about whether the proposed
dressings groups were relevant to current practice.
Interviews revealed strong consensus that a future RCT
should omit ‘complex’ dressings on the basis that these
were not used in routine management of primary
wounds. The survey was developed in response to this
ﬁnding, and subsequently provided evidence that con-
ﬁrmed this (reported in full elsewhere).8 In summary, of
the 1794 wounds surveyed, 1706 (96%) received a dress-
ing, and 63 (4%) did not receive a dressing. In total,
1206/1706 (71%) of the dressed wounds were covered
using a product that matched the pragmatic ‘simple
dressing’ classiﬁcation, with only 18 (1%) wounds
dressed with a product matching the ‘complex’ dressing
deﬁnition.
Further justiﬁcation for omitting ‘complex’ dressings
was associated with concerns about generalisability, given
their heterogeneous nature:
Obstetric surgeon 2001: But once you start into complex
dressings then there must be so many different kinds of
complex dressings […]. Their manufacturers will still be
able to turn round and say ah but this is irrelevant to our
dressing, because ours is impregnated with Beetlejuice
and therefore is much better than either that complex
dressing, that simple dressing or no dressing at all, and
that’s the only thing really isn’t it? So simple against
none will be much cleaner and easier.
Glue as a dressing
Most professionals who were asked about glue acknowl-
edged that it could function as a dressing, if applied
over an already closed wound, but many did not intui-
tively associate glue with the term ‘dressing’. This had
implications for the accuracy of reporting in the wound
dressing survey. To address this difﬁculty, the survey
included a separate item that asked respondents to state
‘any other products’ applied over the closed surgical
wound. Glue was subsequently found to be used as a
dressing in 485/1706 (28%) of the wounds sampled,
accounting for most of the wounds that had not received
a ‘simple’ dressing.8
In alignment with the survey ﬁndings, interviews
revealed considerable variation in professionals’ familiar-
ity and experience of using glue as a dressing. This was
the sole dressing product that was reportedly actively
selected by some of the general surgeons interviewed.
Most professionals working in general surgery were at
least familiar with use of glue as a dressing, while some
working in obstetrics found it hard to conceptualise glue
as a dressing:
Obstetric consultant 2001: I have no understanding of
glue. I know it is used in some contexts, particularly
plastics, A&E, facial stuff, I think. I’ve never seen it used.
I don’t think anyone is using it in gynaecology or obste-
trics in any hospital I’ve ever worked in in my thirty-year
career […]. I’ve never heard of it being used as a
dressing…I’ve thought about it with you here, and I uh,
I don’t quite get the concept.
There was widespread support for evaluating glue’s
effectiveness as a dressing. Professionals who used glue
expressed a range of beneﬁts, including ease of applica-
tion, ease of movement for patients, and the ability to
see the wound clearly. There was nonetheless an
acknowledged need to assess its effectiveness in an RCT
—particularly given its high cost in comparison to
‘simple’ dressings. Updating the Cochrane review to
include ‘glue as a dressing’ revealed only two relevant
RCTs,12 13 with no conclusive evidence to show whether
glue is beneﬁcial over other dressing products, or
leaving wounds exposed.2 This solidiﬁed the decision to
include ‘glue-as-a-dressing’ in the forthcoming pilot
RCT, in place of ‘complex dressings’. Glue will need to
be applied over the entirety of an already closed wound
to be classiﬁed as functioning as a dressing (ie, similar
to the pragmatic deﬁnition of ‘simple dressing’).
Outcome measures for the major RCT
As indicated earlier, patients and professionals noted
that practical issues and patient satisfaction were key
considerations for weighing out future evidence for and
against dressing use. Two new outcome measure tools
were therefore developed to capture the practical
aspects of wound management, and patients’ subjective
experiences of the wound.14 These measures will be
used to collect outcomes in the pilot RCT (phase B),
alongside other speciﬁcally developed patient-centred
tools to capture and measure SSI events,15 16 in line with
the original research brief.
Final trial design
The ﬁnal proposed RCT to be piloted in phase B will
compare ‘simple’ dressings, ‘no dressing’ and ‘glue-as-a-
dressing’ in primary abdominal surgical wounds, based
on pragmatic deﬁnitions developed in phase A. In the
event of wound exudate, the protocol will state that a
simple gauze swab can be applied to the area that is
oozing/bleeding. This swab may be taped in place, but
not around its entire perimeter, and will not have thera-
peutic properties.
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The main outcomes for the pilot RCT will include
whether a patient is eligible, randomised and retained at
30 days post surgery. The pilot RCT will also seek to
examine the feasibility of collecting complete and valid
data for outcomes (eg, SSI rates) that will potentially be
used in a subsequent large trial (as developed in
phase A). Wounds will be examined by blinded assessors
in the pilot and future main RCT. The pilot RCT will
also include a nested methodological study to assess
whether knowledge of dressing strategy allocation inﬂu-
ences surgeons’ approaches to wound closure. This will
have implications for designing approaches to minimis-
ing performance bias in a future deﬁnitive RCT.
Embedded qualitative research will investigate facilitators
and barriers to recruitment and adherence to allocated
dressing groups to further inform the feasibility of a
large-scale RCT. A value of information analysis will be
conducted alongside the pilot RCT to assess whether a
full-scale RCT would be cost-effective from the perspec-
tive of the UK NHS.17
DISCUSSION
This mixed-methods study has demonstrated the bene-
ﬁts of incorporating preliminary feasibility work to opti-
mise trial design, enhancing relevance to current
practice. Novel insights into surgical wound dressing
practices informed changes to an anticipated pilot RCT
of wound dressing strategies. Dressing practices were
found to be ingrained in surgical specialties, although
clinical professionals acknowledged the need for evi-
dence. Dressing selection for primary wounds was
found to be a largely passive process, with most sur-
geons simply applying a ‘default’ dressing that was avail-
able in theatre. These default dressings were classiﬁed
as ‘simple’. ‘Complex’ dressings were not used by any of
the participating hospitals, and were interpreted as
irrelevant to primary surgical wound care.
Unexpectedly, glue did appear to be used as a dressing
by some surgeons, despite the lack of evidence to
support its use. Healthcare professionals and patients
acknowledged the uncertainties around dressing use
and SSI prevention, but reported that dressings may
also have purely practical and/or psychological beneﬁts
or drawbacks.
Phase A of the Bluebelle study has highlighted gaps
and contradictions in the research funder’s topic brief
against which the study was commissioned. The ﬁndings
have altered the design of the pilot RCT that was origin-
ally planned, and informed aspects of the design that
could not be speciﬁed at the outset. The pilot RCT ori-
ginally intended to assess the feasibility of an RCT com-
paring ‘simple’, ‘complex’ and ‘no dressing’, with SSI as
the primary outcome. Interview and survey ﬁndings indi-
cated that the trial comparison groups needed to
change in order for the pilot RCT to be pragmatic and
relevant to current practice. The pilot RCT will now
compare ‘simple dressings’, ‘glue-as-a-dressing’ and ‘no
dressing’ on primary abdominal surgical wounds. Issues
of practicality and acceptability were core considerations
for patients and the surgical teams, thus prompting
development of secondary outcomes to capture and
measure these data.
A key strength of phase A was the mixed-methods
approach, which allowed for triangulation of emerging
ﬁndings and enabled a more rounded view of current
practice. Qualitative methods provided depth of under-
standing and allowed for emergence of new lines of
enquiry that might otherwise have gone unexplored.
The approach to conducting the research and reporting
ﬁndings in an iterative manner allowed the team to
explore new avenues and verify emerging concepts and
theories—both in a qualitative and quantitative manner.
Sharing emerging ﬁndings among the multidisciplinary
team iteratively allowed new objectives to be drawn up
and allocated to the relevant methodological team,
depending on the nature and scope of enquiry. This
enabled the merits of working in a multidisciplinary
team to be fully realised.
There were several limitations to this study. The quali-
tative ﬁndings—particularly exploration of trial accept-
ability—were limited by their reliance on hypothetical
scenarios. Prior research has indicated that while sur-
geons may show support for research in principle, pre-
ferences or biases can lead to intentional or unwitting
inﬂuences on recruitment and trial conduct.18 19
Similarly, patients may have been inclined to produce
socially desirable responses, and may react very differ-
ently if actually presented with the prospect of random-
isation. The pilot RCT will therefore include embedded
qualitative research to investigate challenges with recruit-
ment and adherence to interventions as they occur in
real time.20 Furthermore, the pragmatic deﬁnitions of
dressing strategies were not developed through formal
consensus methods, and have not yet been piloted.
Application of the deﬁnitions in practice may call for
further clariﬁcation and reﬁnement. This will be
assessed in the pilot RCT. Finally, while the insights
emerging from this study would not have been possible
without in-depth qualitative investigation, it should be
noted that the ﬁndings are limited to UK secondary and
tertiary care hospitals. It is also possible that clinicians’
perspectives may differ on the basis of the volume and
nature of procedures they predominantly conduct
(eg, laparoscopic vs open surgery). The clinicians we
interviewed routinely performed both types of opera-
tion, though it is possible that their activities (and thus
experiences) were weighted towards a particular type of
operation. If time and resources were not constrained,
sampling would have taken place across a larger number
of centres, to provide opportunities to build a more
comprehensive sample of maximum variation, based on
factors such as surgical subspecialty.
Given the plethora of dressing products on the
market,21 it was imperative that the dressing comparison
groups in the pilot RCT were reasoned, pragmatic and
relevant. There is little empirical evidence detailing the
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commonality or breadth of dressing types used for surgi-
cal primary wounds, let alone the factors that inﬂuence
choice of dressing. Published commentaries have
alluded to dressing choice being driven by individual
surgeon preference,22 23 and clinical guidelines stipulate
a number of factors professionals should consider in
‘dressing selection’.23 These sources suggest that dress-
ing selection is reasoned, but a key ﬁnding from this
study was the minimal ‘decision-making’ that often took
place in dressing selection for primary wounds. While
surgeon preference may not be as key an issue as antici-
pated, our ﬁndings raise the potential challenge of
negotiating institutional barriers in the event that the
proposed dressing types (eg, glue-as-a-dressing) are not
available in RCT centres. The pilot RCT will provide an
opportunity to identify solutions to these issues, should
they be encountered.
Our ﬁndings have contributed original insights into
the types of dressings currently used for surgical abdom-
inal wounds, and the ways in which these are conceptua-
lised by front-line professionals. The use of glue as a
dressing was unexpected, though it is unclear if this
product had been included in prior studies of dressing
strategies, given the considerable variation in profes-
sionals’ interpretations of what may constitute a ‘dress-
ing’. None of the previous RCTs of dressing strategies
has provided a clear deﬁnition of the intervention
groups compared, raising questions around involvement
of products such as glue, and the consistency of how
wounds were treated in the trial comparison groups.
Development of pragmatic deﬁnitions of ‘dressing’ and
‘no dressing’ in this feasibility study will inform a clear
protocol for evaluating dressing strategies in the forth-
coming pilot.
The qualitative research in particular was central to
this study, informing and instigating other avenues for
investigation. There is growing awareness of the value of
embedding qualitative research in RCTs, though most
published research to date has focused on issues of
acceptance, adherence and patient experience as the
trial proceeds.24 There are comparatively few published
accounts of qualitative research at the pre-trial stage,
whether in the lead up to pilot or main RCTs.24 The
value of pre-trial qualitative research may be particularly
heightened in studies that answer research funders’
commissioned calls. As demonstrated by this study, the
details of these calls cannot be taken for granted; investi-
gators should consider scope for feasibility work that not
only assesses whether a proposed RCT can be delivered,
but considers the relevance of the research questions
proposed. Further, the Bluebelle case study raises ques-
tions about the extent to which feasibility study protocols
can be preplanned. New substudies in Bluebelle were
initiated in response to emerging ﬁndings that could
not have been anticipated. Permitting a degree of ﬂexi-
bility in feasibility study protocols may enhance their
potential to fully address their aims and objectives, espe-
cially in studies with a strong exploratory focus.
This study highlights the value of conducting pre-trial
research at the feasibility stage of RCTs, with respect to
ensuring that the end product—the RCT—is maximally
applicable, and answers the clinical and policy questions
of greatest interest/priority. The feasibility research con-
ducted in phase A has helped to optimise the design of
an ambitious pilot RCT which challenges and questions
an ingrained surgical practice. This was made possible
by the qualitative methodology at the core of the study,
which informed further questions and use of other
research methodologies. The changes made to the pilot
RCT will go some way to ensuring that a future RCT is
relevant to front-line clinicians and patients. While there
are still questions around feasibility, the pre-pilot work
has addressed fundamental issues that may otherwise
have prevented the study from informing the funder’s
decision about commissioning a large-scale RCT.
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